GeneDx claims 11 Myriad patents are invalid

21-08-2014

GeneDx claims 11 Myriad patents are invalid

xrender / Shutterstock.com

The molecular diagnostic testing company GeneDx has petitioned the US Patent and Trademark Office to invalidate 11 patents asserted by Myriad in a lawsuit filed against GeneDx in October 2013.


GeneDx; Myriad; BRCA1; BRCA2; USPTO; patent

LSIPR